Letter From The Editor

Now that we seem to be making progress on overcoming the high rates of death and hospitalizations from Covid-19 and life is starting to move back to some sort of pre-pandemic normalcy, researchers can take more time to look at outcomes in various groups of patients and disease states. Early …

I frequently spend time talking about the virtues of insulin pump therapy and the use of CGM devices. When you add in the smart technology and AI that these systems have, it almost appears to be a no-brainer that if you are an insulin using patient, you should have this …

One of the first things I learned about diabetes came from our publisher, Steve Freed. He told me the best way to avoid diabetes is to live like you have diabetes. I have likely shared this comment with thousands of patients over the years. It makes perfect sense, but is …

This week it looks like a chance to ask the age-old question, “Which came first, the chicken or the egg?” I mean this: when we look at whether the use of insulin, or the increased incidence of hypoglycemia, increase cardiovascular incidences in patients with type 2 diabetes. As more and …

We have always known that patients with diabetes are more likely to get infections, and they are usually more severe. The pandemic that we are just starting to emerge from has certainly proven that, as patients with diabetes were more likely to contract the coronavirus, more likely to be hospitalized, …

Laura Martínez López, PharmD. Candidate 2021, LECOM, College of Pharmacy, presented us with a feature that looks at the benefits of GLP-1 agonists and SGLT-2 inhibitors in decreasing coronary health disease in patients with type 2 diabetes. The results with either product were very positive. So how do you make …

Typically when I start an Editor’s Desk out with the name Dr. Sheri Colberg, everyone always gets ready for an article related to the effects of physical activity, or how to maximize activity for health and glucose control. What most of you do not know is that Dr. Colberg got …

It seems a little unfair that we often take our type 2 patients off oral medication when they begin basal/bolus insulin use, and it makes even less sense that we won’t give a type 1 patient anything but insulin. Over the past 3 years we have had many studies about …

During the time that we have pharmacy interns on rotation with us, we spend time learning about diabetes and the real world effects of the disease, medications and lifestyle changes. One of the first slides we cover is the one from Stratton IM, et al. BMJ. 2000;321(7258):405-412 that describes the …

We often spend considerable time with our patients with type 2 diabetes, discussing the cardiovascular risk that increased insulin resistance, increased weight and cholesterol levels, along with decreased physical activity, can have. It is well documented that these risk factors produce a profound increase in cardiovascular deaths. “But what about …